| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA615329 | F | Cytotoxic activity of compound against uninfected 2.2.15 cells. | Homo sapiens | 13 | ALA1129667 | organism-based format | Scientific Literature | |
| 2. | ALA615330 | F | Anti hepatitis-B virus activity was evaluated in 2.2.15 cells. | Homo sapiens | 14 | ALA1129238 | organism-based format | Scientific Literature | |
| 3. | ALA615332 | F | In vitro anti-HBV activity in 2.2.15 cells | Homo sapiens | 2 | ALA1151095 | organism-based format | Scientific Literature | |
| 4. | ALA615333 | F | In vitro anti-HBV activity in 2.2.15 cells; Not determined | Homo sapiens | 1 | ALA1151095 | organism-based format | Scientific Literature | |
| 5. | ALA615334 | F | The compound was tested in vitro for the anti-HBV activity against 2.2.15 cells | Homo sapiens | 10 | ALA1132363 | organism-based format | Scientific Literature | |
| 6. | ALA615335 | F | The compound was tested in vitro for the anti-HBV activity in 2.2.15 cells | Homo sapiens | 2 | ALA1132363 | organism-based format | Scientific Literature | |
| 7. | ALA615336 | F | Cytotoxicity in 2.2.15 cells | Homo sapiens | 2 | ALA1151095 | organism-based format | Scientific Literature | |
| 8. | ALA615337 | F | Cytotoxicity in 2.2.15 cells; Not determined | Homo sapiens | 1 | ALA1151095 | organism-based format | Scientific Literature | |
| 9. | ALA615338 | F | Inhibitory activity of compound against hepatitis B virus (HBV) in growing cultures of 2.2.15 cells | Homo sapiens | 13 | ALA1129667 | organism-based format | Scientific Literature | |
| 10. | ALA615339 | F | The growth inhibition activity for the compound was evaluated in 2.2.15 cells. | Homo sapiens | 14 | ALA1129238 | organism-based format | Scientific Literature | |
| 11. | ALA615340 | F | Selectivity index was determined from the ratio of IC50 to the EC50 values evaluated in 2.2.15 cells. | Homo sapiens | 3 | ALA1129238 | organism-based format | Scientific Literature | |
| 12. | ALA625209 | A | In vivo absorption in Caco-2 cell line monolayers was determined | Homo sapiens | 3 | ALA1134157 | organism-based format | Scientific Literature | |
| 13. | ALA626235 | A | The maximum plasma concentration (100 mg/kg) administered orally in human | Homo sapiens | 1 | ALA1130253 | organism-based format | Scientific Literature | |
| 14. | ALA622412 | A | The maximum plasma concentration (200 mg/kg) administered orally in human | Homo sapiens | 1 | ALA1130253 | organism-based format | Scientific Literature | |
| 15. | ALA623118 | A | The maximum plasma concentration (400 mg/kg) administered orally in human | Homo sapiens | 1 | ALA1130253 | organism-based format | Scientific Literature | |
| 16. | ALA623286 | A | The maximum plasma concentration (800 mg/kg) administered orally in human | Homo sapiens | 1 | ALA1130253 | organism-based format | Scientific Literature | |
| 17. | ALA624170 | A | The area under curve (100 mg/kg) administered orally in humans | Homo sapiens | 1 | ALA1130253 | organism-based format | Scientific Literature | |
| 18. | ALA877488 | A | The area under curve (200 mg/kg) administered orally in humans | Homo sapiens | 1 | ALA1130253 | organism-based format | Scientific Literature | |
| 19. | ALA624178 | A | The area under curve (400 mg/kg) administered orally in humans | Homo sapiens | 1 | ALA1130253 | organism-based format | Scientific Literature | |
| 20. | ALA627690 | A | The area under curve (800 mg/kg) administered orally in humans | Homo sapiens | 1 | ALA1130253 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!